{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T22:01:26Z","timestamp":1783980086656,"version":"3.55.0"},"reference-count":16,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T00:00:00Z","timestamp":1500422400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T00:00:00Z","timestamp":1500422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Clin Pract"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1111\/ijcp.12968","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T13:22:50Z","timestamp":1500470570000},"page":"e12968","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Switching to a rilpivirine\/emtricitabine\/tenofovir single-tablet regimen in RNA-suppressed patients infected with human immunodeficiency virus 1: Effectiveness, safety and costs at 96\u00a0weeks"],"prefix":"10.1155","volume":"71","author":[{"given":"Paula","family":"Arrabal-Dur\u00e1n","sequence":"first","affiliation":[{"name":"Pharmacy Department; Hospital General Universitario Gregorio Mara\u00f1\u00f3n; Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM); Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4324-1387","authenticated-orcid":false,"given":"Carmen G","family":"Rodr\u00edguez-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Pharmacy Department; Hospital General Universitario Gregorio Mara\u00f1\u00f3n; Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM); Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Chamorro-de-Vega","sequence":"additional","affiliation":[{"name":"Pharmacy Department; Hospital General Universitario Gregorio Mara\u00f1\u00f3n; Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM); Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paloma","family":"Gij\u00f3n-Vidaurreta","sequence":"additional","affiliation":[{"name":"Clinical Microbiology and Infectious Diseases Department; Hospital General Universitario Gregorio Mara\u00f1\u00f3n; Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM); Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Herranz-Alonso","sequence":"additional","affiliation":[{"name":"Pharmacy Department; Hospital General Universitario Gregorio Mara\u00f1\u00f3n; Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM); Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Sanjurjo-S\u00e1ez","sequence":"additional","affiliation":[{"name":"Pharmacy Department; Hospital General Universitario Gregorio Mara\u00f1\u00f3n; Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n (IiSGM); Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,7,19]]},"reference":[{"key":"10.1111\/ijcp.12968-BIB0001|ijcp12968-cit-0001","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1001\/jama.2014.8722","article-title":"Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel","volume":"312","author":"G\u00fcnthard","year":"2014","journal-title":"JAMA"},{"key":"10.1111\/ijcp.12968-BIB0002|ijcp12968-cit-0002","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.eimc.2016.02.028","article-title":"[Executive summary of the GESIDA\/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2016)]","volume":"34","author":"AIDS Study Group (GESIDA) of the Spanish Society of Infectious Diseases, Clinical Microbiology, the National AIDS Plan","year":"2016","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1111\/ijcp.12968-BIB0003|ijcp12968-cit-0003","first-page":"61","article-title":"New option for management of HIV-1 infection in treatment-naive patients: once-daily, fixed-dose combination of rilpivirine-emtricitabine-tenofovir","volume":"4","author":"Patel","year":"2012","journal-title":"HIVAIDS (Auckl)"},{"key":"10.1111\/ijcp.12968-BIB0004|ijcp12968-cit-0004","first-page":"531","article-title":"Triple-combination rilpivirine, emtricitabine, and tenofovir (CompleraTM\/Eviplera\u2122) in the treatment of HIV infection","volume":"7","author":"Bernardini","year":"2013","journal-title":"Patient Prefer Adherence"},{"key":"10.1111\/ijcp.12968-BIB0005|ijcp12968-cit-0005","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/QAD.0000000000000087","article-title":"Simplification to rilpivirine\/emtricitabine\/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants","volume":"28","author":"Palella","year":"2014","journal-title":"AIDS"},{"key":"10.1111\/ijcp.12968-BIB0006|ijcp12968-cit-0006","doi-asserted-by":"crossref","first-page":"ofv018","DOI":"10.1093\/ofid\/ofv018","article-title":"Switch to Rilpivirine\/Emtricitabine\/Tenofovir Single-Tablet Regimen of Human Immunodeficiency Virus-1 RNA-Suppressed Patients, Agence Nationale de Recherches sur le SIDA et les H\u00e9patites Virales CO3 Aquitaine Cohort, 2012-2014","volume":"2","author":"Cazanave","year":"2015","journal-title":"Open Forum Infect Dis."},{"key":"10.1111\/ijcp.12968-BIB0007|ijcp12968-cit-0007","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/hiv.12183","article-title":"Switching to emtricitabine, tenofovir and rilpivirine as single tablet regimen in virologically suppressed HIV-1-infected patients: a cohort study","volume":"16","author":"Gantner","year":"2015","journal-title":"HIV Med"},{"key":"10.1111\/ijcp.12968-BIB0008|ijcp12968-cit-0008","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1097\/QAI.0000000000000401","article-title":"Evaluation of the efficacy and safety of switching to tenofovir, emtricitabine, and rilpivirine in treatment-experienced patients","volume":"68","author":"Surgers","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/ijcp.12968-BIB0009|ijcp12968-cit-0009","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1097\/QAI.0000000000000727","article-title":"Switching to coformulated rilpivirine\/emtricitabine\/tenofovir in virologically suppressed patients: data from a multicenter cohort","volume":"70","author":"Pinnetti","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/ijcp.12968-BIB0010|ijcp12968-cit-0010","doi-asserted-by":"crossref","first-page":"20037","DOI":"10.7448\/IAS.18.1.20037","article-title":"Efficacy and safety in clinical practice of a rilpivirine, tenofovir and emtricitabine single-tablet regimen in virologically suppressed HIV-positive patients on stable antiretroviral therapy","volume":"18","author":"Gianotti","year":"2015","journal-title":"J Int AIDS Soc"},{"key":"10.1111\/ijcp.12968-BIB0011|ijcp12968-cit-0011","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3851\/IMP3010","article-title":"Efficacy and safety of a switch to rilpivirine-based regimens in treatment-experienced HIV-1-infected patients: a cohort study","volume":"21","author":"Gazaignes","year":"2016","journal-title":"Antivir Ther"},{"key":"10.1111\/ijcp.12968-BIB0012|ijcp12968-cit-0012","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1111\/ijcp.12968-BIB0013|ijcp12968-cit-0013","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1086\/503914","article-title":"Web resources for HIV type 1 genotypic-resistance test interpretation","volume":"42","author":"Liu","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1111\/ijcp.12968-BIB0014|ijcp12968-cit-0014","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1093\/jac\/dku294","article-title":"Initiation of rilpivirine, tenofovir and emtricitabine (RPV\/TDF\/FTC) regimen in 363 patients with virological vigilance assessment in \u2018real life\u2019","volume":"69","author":"Amiel","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1111\/ijcp.12968-BIB0015|ijcp12968-cit-0015","doi-asserted-by":"crossref","first-page":"5612","DOI":"10.1128\/AAC.01421-13","article-title":"Rilpivirine inhibits drug transporters ABCB1, SLC22A1, and SLC22A2 in vitro","volume":"57","author":"Moss","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1111\/ijcp.12968-BIB0016|ijcp12968-cit-0016","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/cid\/ciu046","article-title":"Lower pill burden and once-daily antiretroviral treatment regimens for HIV infection: a meta-analysis of randomized controlled trials","volume":"58","author":"Nachega","year":"2014","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijcp.12968","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ijcp.12968\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:10:11Z","timestamp":1643350211000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijcp.12968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,19]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"URL":"https:\/\/doi.org\/10.1111\/ijcp.12968","archive":["Portico"],"relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7,19]]}}}